Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03746405 · ClinicalTrials.gov registry record · NA
Effects of Connectivity-based rTMS and State-Dependency on Amygdala Activation
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03746405 is a NA study that has completed, run by Duke University. The registered enrollment target is 25 participants.
The verdict
NCT03746405, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Posttraumatic stress disorder (PTSD) is a highly debilitating disease with response rates to pharmacological treatment rarely exceeding 60%. Preliminary attempts have been made to use repetitive transcranial magnetic stimulation (rTMS) as a non-pharmacological treatment alternative, but thus far rTMS approaches have demonstrated only modest efficacy. A major factor contributing to these limited effects stems from the depth penetration of TMS, which is not sufficient to directly modulate deep subcortical structures, such as the amygdala, that are affected in PTSD. Moreover, while rTMS effects have been shown to be state-dependent, (i.e. vary substantially according to the neural state during stimulation), this important factor is rarely considered during the clinical application of rTMS. The current study addresses both of these limitations to improve the therapeutic efficacy of rTMS for PTSD. Here we will develop a protocol to test if connectivity-based rTMS is able to modulate amygdala activity through the functional connections with medial prefrontal cortex, taking advantage of state-dependency to enhance rTMS effects by actively engaging the amygdala through a fear perception task. BOLD activation in the amygdala and its connectivity with the frontal cortex will constitute the primary outcomes to test rTMS efficacy. Heart rate variability and skin galvanic responses, acquired during the presentation of fearful faces, will be used as continuous moderators of task engagement during rTMS. If successful, this study will pave the way for a large-scale study to investigate whether state-dependent, connectivity-based rTMS of the amygdala can improve rTMS efficacy as a clinical treatment for PTSD.
Interventions
- DEVICE repetitive transcranial magnetic stimulation
- DEVICE Sham repetitive transcranial magnetic stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-06-16 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03746405
The ClinicalTrials.gov registry entry for NCT03746405 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which repetitive transcranial magnetic stimulation is the first listed.
NCT03746405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03746405 about?
NCT03746405 is a clinical study titled "Effects of Connectivity-based rTMS and State-Dependency on Amygdala Activation". Posttraumatic stress disorder (PTSD) is a highly debilitating disease with response rates to pharmacological treatment rarely exceeding 60%. Preliminary attempts have been made to use repetitive transcranial magnetic stimulation (rTMS) as a non-pharmacological treatment alternative, but thus far rTM...
What is the current status of trial NCT03746405?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-06-16. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT03746405?
The interventions under investigation include: repetitive transcranial magnetic stimulation (DEVICE), Sham repetitive transcranial magnetic stimulation (DEVICE).
Who is sponsoring clinical trial NCT03746405?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.